Patient Characteristics
| Characteristics | No. of patients included in analysis (n = 73) |
| Median age (y) | 68 (IQR, 63–73) |
| Median PSA at diagnosis (ng/dL) | 14.0 (IQR, 6–35) |
| Clinical T stage at diagnosis | |
| T1c | 17 (23.3) |
| T2a | 11 (15.1) |
| T2b | 19 (26.0) |
| T2c | 8 (11.0) |
| T3a | 14 (19.2) |
| T3b | 4 (5.5) |
| Postbiopsy Gleason sum at diagnosis (n) | |
| 6 | 3 (4.1) |
| 7 | 9 (12.3) |
| 8 | 33 (45.2) |
| 9 | 25 (34.3) |
| 10 | 3 (4.1) |
| Imaging T stage | |
| T2c | 12 (16.4) |
| T3a | 26 (35.6) |
| ≥T3b | 35 (48.0) |
| Imaging N stage | |
| cN0 | 56 (76.7) |
| cN1 | 15 (20.6) |
| Intermediate | 2 (2.7) |
| Imaging M stage (bone metastasis) | |
| cM0 | 71 (97.3) |
| cM1 | 2 (2.7) |
| Postoperative T stage | |
| T2a | 2 (2.7) |
| T2b | 3 (4.1) |
| T2c | 15 (20.6) |
| T3a | 20 (27.4) |
| ≥T3b | 33 (45.2) |
| Postoperative N stage | |
| pN0 | 48 (66.7) |
| pN1 | 25 (34.3) |
| LNs | |
| Total no. removed | 1,902 |
| Mean removed/patients ± SD | 26.1 ± 16.9 |
| Median | 23 (IQR, 17–29) |
| Total no. of positive LNs | 165 |
Data in parentheses are percentages unless otherwise indicated.
Gs = Gleason sum; LNs = lymph nodes; DRE = digital rectal examination.